Zenas BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	1,170	342	-	-
Enterprise Value	880	-44	-	-
Last Close Price	21.80	8.19	-	-
PS Ratio	60.95	68.45	-	-
PB Ratio	4.68	1.10	-	-
P/TBV Ratio	5.96	1.10	-	-
Debt / Equity Ratio	0.00	0.00	0.87	0.03
Asset Turnover	0.04	0.02	0.70	-
Quick Ratio	5.57	6.12	2.44	2.59
Current Ratio	5.66	6.21	2.57	2.64
Return on Equity (ROE)	-68.33%	-93.22%	-102.89%	-
Return on Assets (ROA)	-33.72%	-46.76%	-23.77%	-
Return on Capital Employed (ROCE)	-72.60%	-52.40%	-60.40%	-154.70%
Earnings Yield	-16.23%	-45.87%	-	-
FCF Yield	-13.55%	-35.00%	-	-
Buyback Yield / Dilution	-1252.33%	-762.01%	-2.61%	-

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q